Global Regenerative Medicine Industry was valued at USD 28 Billion in the year 2016. Global Regenerative Medicine Industry is further estimated to grow at a CAGR of 23.2% from 2018 to reach USD 123 Billion by the year 2025.
Reconstructive surgeries for bones and joints is the backbone of the regenerative medicine market. Geologically, because of the predominance of the bone and joint reconstruction industry, the US has the greatest space. This is trailed by Europe. Notwithstanding, because of late positive enactment in Japan and Europe, the stem cell arena will develop all the more significantly in these locales throughout the following five years. By 2025, it is conceivable that Europe will outperform the US advertise as for undifferentiated cell applications, and this will turn out to be almost certain if the Trump Administration limits legislation and funding.
In addition, high investments by government and private organizations that support R&D, further encourage industry progress. Initiatives by government organizations to support stem cell & regenerative medicine R&D by providing funds and infrastructure facilities along with initiating various programs is expected to influence growth.
Major market players in Regenerative Medicine Industry are Astellas Institute for Regenerative Medicine (Ocata Therapeutics), AstraZeneca, Athersys, Baxter International (Baxalta, Shire), Bayer, Caladrius Biosciences (NeoStem), Celgene, CHA Biotech, Chimerix, Cynata Therapeutics, Cytori Therapeutics, Eisai, Genzyme (Sanofi), GSK, Janssen, InCyte Corp, MedImmune, MEDIPOST, Merck, Mesoblast, Millennium Pharmaceutical, NuVasive, Osiris Therapeutics, Plasticell, Pluristem Therapeutics, Pfizer, SanBio Current Stem Cell Trials, Seattle Genetics Current Stem Cell Trials, StemCells Inc, STEMCELL Technologies, Takara Bio, Teva Current Stem Cell Trials, Tigenix
Regenerative Medicine Industry Segmentation:
Regenerative Medicine By Product
Mono Avalanche Airbags
Dual Avalanche Airbags
Regenerative Medicine Industry Overview, By Application
Regenerative Medicine Industry Overview, By Region
• Rest of Europe
• Rest of Asia-Pacific
• Latin America
• Middle East & Africa"